The antiproliferative effect of vitamin d3 analogues

Dermatology

Volumn 192, Issue 3, 1996, Pages 195-197

  Carlherg, Carsten ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL DERIVATIVE;

CELL PROLIFERATION; EDITORIAL; HYPERCALCEMIA; HYPERCALCIURIA; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; SOFT TISSUE CALCIFICATION;

EID: 0029877561     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246364     Document Type: Article

References (27)

1. Frampton RJ. Omond SA. Eisman JA: Inhibition of human cancer cell growth by 1,25-di-hydroxyvitamin D, metabolites. Cancer Res 1983;43:4443-4447.
2. Mangelsdorf DJ. Koeffler HP. Donaldson CA. Pike JW, Haussler MR: 1.25-Dihydroxyvita-min D, induced differentiation in a human pro-myelocytic leukemia cell line HL-60: Receptor-mediated maturation to macrophage-like cells. J Cell Biol 1984:98:391-398.
3. Biklc DD: Vitamin D: New actions, new analogs. new therapeutic potential. Endocr Rev 1992;13:765-784.
4. Vietlt R: The mechanisms of vitamin D toxicity. Bone Miner 1990:11:267-272.
5. Calvcrlcy MJ. Jones G: Vitamin D. Antitumor Steroids 1992. San Diego. Academic Press. 1992. pp 193-270.
6. Jones G. Calverley MJ: A dialogue on analogues. Trends Endocrinol Mctah 1993:4: 297-303.
7. Pols HAP. Birkenhager JC. van Lceuven JPTM: Vitamin D analogues: From molecule to clinical application. Clin Endocrinol 1994: 40:285-291.
8. Bouillon R. Okamura WII. Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995; 16: 200-257.
9. Carlberg C: Mechanisms of nuclear signalling by vitamin D,: Interplay with retinoid and thyroid hormone signalling. Eur J Biochcm 1995: 231:517-527.
10. Simpson RU. Hsu T. Begley DA. Mitchell BS. Alizadeh BN: Transcriptional regulation of the c-»nr protooncogenc by 1,25-dihydroxy-vitamin D, in HL-60 promyelocytic leukemia cells. J Biol Client 1987:262:4104-4108.
11. Jiang H, Lin J. Su Z-Z, Collart FR. Huberman E, Fisher PB: Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21. WAFI/CIPI expression in the absence of p53. Oncogene 1994:9:3397-3406.
12. Nayeri S. Danielsson C. Kahlen J-P. Schrader M, Mathiasen IS. Binderup L. Carlberg C: The antiproliferative effect of vitamin D analogues is not related to the AP-I pathway, but related to promoter selectivity. Oncogene 1995:11: 1853-1858.
13. Nayeri S. Kahlen J-P. Danielsson C. Schrader M. Mathiasen IS. Binderup I. Carlberg C: Induction of a very potent 1,25-dihydroxy vitamin D, response element identified in the rat atrial natriuretic factor gene by selected 20-epi analogues of 1,25-dihydroxy vitamin D. Submitted.
14. Schrader M. Nayeri S. Kahlen J-P. Muller KM. Carlberg C: Natural vitamin D, response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivalion. Mol Cell Biol 1995:15:1154-1161.
15. Mork Hansen C. Carlberg C: The potent antiproliferative effect of 20-epi analogues of 1.25-dihydroxyvitamin D, in human breast cancer MCF-7 cells is related to promoter selectivity. Submitted.
16. James SY. Mackay AG, Colston KW: Vitamin D derivatives in combination with 9-ro-reti-noic acid promote active cell death in breast cancer cells. J Mol Endocrinol 1995:14: 391-394.
17. Elstner E, Linkcr-Israeli M. Said J. Umicl J. de Vos S, Shintaku IP. Heber D. Binderup L, Uskokovic M. Koeffler HP: 20-cpi-Vitamin D, analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 1995;55:2822-2830.
18. Fanjul A. Dawson MI, Hobbs PD, Jong L. Cameron JF. Harlcv E. Graupncr G, Lu X-P. Pfahl M: A new class of retinoids with selective inhibition of AP-I inhibits proliferation. Nature 1994;372:107-111.
19. Chen J-Y. Penco S. Ostrowski J, Balagucr P. Pons M. Slarrell JE. Reczek P. Chambon P. Gronemcyer H: RAR-specific agonist/antago-nisl which dissociate transactivation and API transrepression inhibit anchorage-independent cel! proliferation. EMBO J 1995:14: 1187-1197.
20. Schiile R, Umcsono K. Mangelsdorl DJ. Bo-lado J. Pike JW. Evans RM: Jun-Fosand receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990:61:497-504.
21. Liang P. Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992:257: 967-971.
22. Sato H. Sugimoto I. Fukuoka M. Ohta T, Ki-yoki M: The effect of l.24(R)(OH), D, cream and ointment on epidermal proliferation and differentiation in mice. Dermatology 1996; 192:233-238.
23. Abe J. Nakano T. Nishii Y, Matsumoto T, Ogata E. Ikeda K: A novel vitamin D, analog 22-oxa-1,25-dihydroxy vitamin D, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 1991:129:832-837.
24. Colston KW. Mackay AG. James SY. Bindcrup L. Chancier S, Coombes PC: EBI089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Bio-chem Pharmacol 1992:44:2273-2280.
25. Colston KW. Chander SK. Mackay AG. Coombes RC: Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochcm Pharmacol 1992: 44:693-702.
26. Kragballe K. Gjertsen BT. Dclloop D, Karlsmark T. van de Kerkhof PCM. Larko O. Tikjob G. Nieboer C. Strand A. Roed-Petersen J: Double-blind, right/left comparison of calcipolriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991:337:193-196.
27. Kissmeyer A-M. Binderup L: Calcipolriol (MC903): Pharmacokinetics in rats and biological activities of metabolites. Biochem Pharmacol 1991;41:1601-1606.